Gram stain-guided antibiotic choice: a GRACEful method to safely restrict overuse of broad-spectrum antibiotic agents
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gram stain-guided antibiotic choice: a GRACEful method to safely restrict overuse of broad-spectrum antibiotic agents ; volume:22 ; number:1 ; day:14 ; month:12 ; year:2018 ; pages:1-3 ; date:12.2018
Critical care ; 22, Heft 1 (14.12.2018), 1-3, 12.2018
- Creator
-
Yoshimura, Jumpei
Yamakawa, Kazuma
Kinoshita, Takahiro
Fujimi, Satoshi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-018-2270-z
- URN
-
urn:nbn:de:101:1-2019013123285267995507
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yoshimura, Jumpei
- Yamakawa, Kazuma
- Kinoshita, Takahiro
- Fujimi, Satoshi
- SpringerLink (Online service)
Other Objects (12)
Integrated in vitro and in silico studies for optimisation of broad-spectrum antibiotic combination therapy
Effect of Broad-Spectrum Antibiotic De-escalation on Critically Ill Patient Outcomes: A Retrospective Cohort Study
Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic
No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course
Reimagining Chitosan‐Based Antimicrobial Biomaterials to Mitigate Antibiotic Resistance and Alleviate Antibiotic Overuse: A Review
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
Contribution of Penicillin Allergy Labels to Second-Line Broad-Spectrum Antibiotic Prescribing for Pediatric Respiratory Tract Infections
P200: No need for initial broad-spectrum empiric antibiotic coverage after surgical drainage of orthopaedic implant infections
Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals
Perinatal treatment of parents with the broad-spectrum antibiotic enrofloxacin aggravates contact sensitivity in adult offspring mice
Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998–2004
A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy
Integrated in vitro and in silico studies for optimisation of broad-spectrum antibiotic combination therapy
Effect of Broad-Spectrum Antibiotic De-escalation on Critically Ill Patient Outcomes: A Retrospective Cohort Study
Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic
No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course
Reimagining Chitosan‐Based Antimicrobial Biomaterials to Mitigate Antibiotic Resistance and Alleviate Antibiotic Overuse: A Review
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
Contribution of Penicillin Allergy Labels to Second-Line Broad-Spectrum Antibiotic Prescribing for Pediatric Respiratory Tract Infections
P200: No need for initial broad-spectrum empiric antibiotic coverage after surgical drainage of orthopaedic implant infections
Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals
Perinatal treatment of parents with the broad-spectrum antibiotic enrofloxacin aggravates contact sensitivity in adult offspring mice
Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998–2004
A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy
Integrated in vitro and in silico studies for optimisation of broad-spectrum antibiotic combination therapy
Effect of Broad-Spectrum Antibiotic De-escalation on Critically Ill Patient Outcomes: A Retrospective Cohort Study
Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic
No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course
Reimagining Chitosan‐Based Antimicrobial Biomaterials to Mitigate Antibiotic Resistance and Alleviate Antibiotic Overuse: A Review
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study
Contribution of Penicillin Allergy Labels to Second-Line Broad-Spectrum Antibiotic Prescribing for Pediatric Respiratory Tract Infections
P200: No need for initial broad-spectrum empiric antibiotic coverage after surgical drainage of orthopaedic implant infections
Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals
Perinatal treatment of parents with the broad-spectrum antibiotic enrofloxacin aggravates contact sensitivity in adult offspring mice
Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998–2004